InflaRx (IFRX) Preferred Shares Issued (2017)
InflaRx's (IFRX) quarterly Preferred Shares Issued came in at $30.0 million in Q4 2017, up 1779.64% quarter-over-quarter from $1.6 million in Q1 2017.
InflaRx (IFRX) Preferred Shares Issued (2017) Analysis & Trends
InflaRx has disclosed Preferred Shares Issued across 1 years of filings, most recently posting $30.0 million for Q4 2017.
- Preferred Shares Issued for Q4 2017 came in at $30.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was $30.0 million (up 1779.64% YoY), and the FY2017 annual result was $31.8 million, down 7.3% from the prior year.
- Preferred Shares Issued came in at $30.0 million for Q4 2017 at InflaRx, up from $1.6 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $30.0 million in Q4 2017 to a low of $1.6 million in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 30.04 Mn |
| Dec 31, 2017 | 30.04 Mn |
| Mar 31, 2017 | 1.60 Mn |
| Mar 31, 2017 | 1.60 Mn |